logo
Select company
Select metric
14.85%Return on Equity
VS
Market
80
Sector
91
Industry
94
History
38
$ 6.74Close
$ 5.62 - $ 9.75 52-Week Range
Ticker Information

Ticker

MDXG

Company Name

MIMEDX GROUP INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MIMEDX GROUP INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MDXG - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 216.62M$ 32.17M14.85%
3/31/2025$ 202.78M$ 40.18M19.82%
12/31/2024$ 193.11M$ 42.42M21.97%
9/30/2024$ 181.01M$ 93.64M51.73%
6/30/2024$ 168.04M$ 92.31M54.93%
3/31/2024$ 155.73M$ 74.16M47.62%
12/31/2023$ 142.72M$ 58.23M40.8%
9/30/2023$ 1.33M$ -2.54M-191.28%
6/30/2023$ -12.67M$ -19.4M0%
3/31/2023$ -17.95M$ -31.37M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MIMEDX GROUP INC's latest trailing twelve months (TTM) ROE stands at -565.23%.
  • Over the past 5 years, MIMEDX GROUP INC's average ROE has been -2053.04%.
  • The median ROE for MIMEDX GROUP INC during this period was 20.89%
  • MIMEDX GROUP INC reached its highest ROE over the past 5 years at 54.93%.
  • The lowest ROE recorded by MIMEDX GROUP INC in the same timeframe -20025.61%

MIMEDX GROUP INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
ARDX : ARDELYX INC -40.41%INVA : INNOVIVA INC 5.41%MNKD : MANNKIND CORP -RCUS : ARCUS BIOSCIENCES INC -54.28%IOVA : IOVANCE BIOTHERAPEUTICS INC -55.82%XERS : XERIS BIOPHARMA HOLDINGS INC -ARVN : ARVINAS INC -11.92%DNA : GINKGO BIOWORKS HOLDINGS INC -51.42%AUPH : AURINIA PHARMACEUTICALS INC 18.08%AKBA : AKEBIA THERAPEUTICS INC -124.84%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for MIMEDX GROUP INC is calculated as follows: Net Inc. Cmn. [ $ -72.75M ] / Equity [ $ 12.87M ]
(=) ROE [ -565.23% ]

MDXG - Return on Equity, Last 5 years

-20025.61%

Minimum

Dec 31, 2021

54.93%

Maximum

Jun 30, 2024

-2053.04%

Average

20.89%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.52% with a standard deviation of 22.72%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.49%
average1.52%
median6.45%
std22.72%